Because quality criteria for PACS have not yet been standardized, institutions are left to wrestle with the components that contribute to systemwide quality mostly on their own.Understanding quality assurance of PACS workstations is especially
Because quality criteria for PACS have not yet been standardized, institutions are left to wrestle with the components that contribute to systemwide quality mostly on their own.
Understanding quality assurance of PACS workstations is especially important now that the trend away from CRT to LCD monitors has gathered steam.
"How you approach a flat-panel world is different from a CRT world," said Dr. Jeffrey B. Mendel, chair of radiology at Caritas St. Elizabeth Medical Center in Boston.
The types of artifacts that users run into with LCDs are different, and the causes and solutions are different, he said.
Many experts agree that flat panels will soon replace CRTs completely in PACS.
"We just put in a three-hospital PACS, and we have no CRTs whatsoever," Mendel said.
Mendel has given a PACS quality assurance course at the RSNA meeting the past few years. He advises institutions to carefully assess their monitor needs before beginning to shop for PACS.
If they then codify those needs into a document for doing acceptance testing, they will have a continuum - from what they are looking for to what they are contracting for to what they need to test for.
"They will then know that what they thought they were getting is what they got," Mendel said.
QA is also important because most PACS have both diagnostic-quality and clinical (nondiagnostic) workstations on their networks.
"Clinical workstations don't need to be dedicated, high-quality medical-grade monitors. But without an assessment of monitor needs before purchase to determine what criteria are actually needed, you can end up with videocards that can't be calibrated," he said. "So you can never make the images look good."
When that happens, clinicians sometimes pester radiologists because they don't have a monitor showing the detail they need for their own evaluations.
QA programs are also essential because monitor quality can degrade so gradually it may go unnoticed.
The joke is, the only time radiologists complain about monitor image quality is when they can't read the patient's name, Mendel said.
In order for radiologists to efficiently read eight hours a day off a PACS workstation, all quality measurements need to stay at a high level. Before PACS, radiologists could tell if a film was good quality just by looking at it. No more.
"With computer-based systems, it isn't enough to just look at the image to know whether the quality is there. To make sure you are getting the data, you need a rigorous QA program in place, to verify that the quality of the image you see is the best it can possibly be," Mendel said.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.